The progression of Parkinson’s disease is characterized by a reduced ability of the brain to produce dopamine, a neurotransmitter responsible for the messaging that controls body movement. For this reason, much research in the area concentrates on developing therapies that can arrest this slide, and scientists in Finland have now uncovered a promising path forward...